Lenskart IPO and Groww IPO are attracting attention, with Lenskart concluding its subscription and Groww starting its process ...

In a world increasingly driven by sustainability, precision, and intelligent automation, Chinese entrepreneur Minglu Chen ...

NurExone’s U.S. subsidiary, Exo-Top Inc., is advancing plans for the establishment of a GMP-compliant facility dedicated to naive exosome production. The Company believes participation in ARMI’s ...

FDA recently issued the draft guidance, Quality Management System Information for Certain Premarket Submission Reviews. The guidance is designed ...

MediWound Successfully Completes Commissioning of Expanded GMP Manufacturing Facility for NexoBrid® Newly commissioned facility marks a significant development toward a sixfold production capacity inc ...

Matica Biotechnology, Inc. ("Matica Bio"), a leading viral vector CDMO specializing in advanced therapies, today announced a strategic partnership with Calidi Biotherapeutics, Inc. ("Calidi"), a ...

Researchers from IIT Madras and Ohio State University have developed an AI framework called PURE that can quickly generate drug-like molecules suitable for real-world synthesis. This innovation aims ...

ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that ...

MediWound (MDWD) announced the successful completion of the commissioning process for its expanded GMP manufacturing facility in Yavne, Israel.

Lumen Biosciences Brian Finrow breaks down Chinas biotech playbook and explores ways the U.S. can adapt it for its own continued success.

The draft guidance, which is touted as a way to reduce the cost and time-associated burden of biosimilar development, has ...